6 December 2021

Kanabo Group PLC

("Kanabo" or the "Company")

Exercise of Options and Total Voting Rights

Kanabo Group Plc (LSE:KNB), a medical cannabis R&D Company that focuses on the distribution of cannabis-derived products for medical patients and wellness CBD consumers, announces that it has issued 145,652 new ordinary shares following the exercise of options granted under its New Share Option Scheme (employees), as detailed in the prospectus dated 29 January 2021.

Application will be made for the ordinary shares to be admitted to the Standard List segment of the Official List and to trading on the main market of the London Stock Exchange plc ("Admission"). It is expected that Admission will become effective and that dealings in the ordinary shares will commence at 8.00am on or around 8 December 2021.

Following Admission, the total issued share capital of the Company will consist of 369,961,168 ordinary shares of 2.5 pence each carrying the right to one vote. There are no shares currently held in treasury. The total number of voting rights in the Company will therefore be 369,961,168 and this figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Rules and Transparency Rules.

The Directors of the Company accept responsibility for the contents of this announcement.

For further information, please visit http://www.kanabogroup.com/ or contact the following: